EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CareDx's Enterprise Value is $870.7 Mil.
CareDx's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $20.1 Mil. Therefore, CareDx's EV-to-FCF for today is 43.21.
The historical rank and industry rank for CareDx's EV-to-FCF or its related term are showing as below:
CDNA'
s EV-to-FCF Range Over the Past 10 Years
Min: -532.65 Med: -11.99 Max: 1165.58
Current: 43.21
During the past 13 years, the highest EV-to-FCF of CareDx was 1165.58. The lowest was -532.65. And the median was -11.99.
CDNA's EV-to-FCF is ranked worse than 71.15% of 104
companies
in the Medical Diagnostics & Research industry
Industry Median: 24.645
vs CDNA: 43.21
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2025-07-08), CareDx's stock price is $18.45.
CareDx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $1.150. Therefore, CareDx's PE Ratio (TTM) for today is 16.04.
CareDx EV-to-FCF Historical Data
The historical data trend for CareDx's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, CareDx's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CareDx's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, CareDx's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where CareDx's EV-to-FCF falls into.
CareDx's current Enterprise Value is $870.7 Mil.
CareDx's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $20.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareDx (NAS:CDNA) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CareDx's share price for today is $18.45.
CareDx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.150.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CareDx EV-to-FCF Related Terms
Thank you for viewing the detailed overview of CareDx's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CDNA has been successfully added to your 